Статті в журналах з теми "High-grade serous ovarian carcinoma"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "High-grade serous ovarian carcinoma".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Casey, Laura, and Naveena Singh. "Ovarian High-Grade Serous Carcinoma." Surgical Pathology Clinics 12, no. 2 (June 2019): 515–28. http://dx.doi.org/10.1016/j.path.2019.01.007.
Повний текст джерелаPannu, Harpreet K., Weining Ma, Emily Craig Zabor, Chaya S. Moskowitz, Richard R. Barakat, and Hedvig Hricak. "Enhancement of Ovarian Malignancy on Clinical Contrast Enhanced MRI Studies." ISRN Obstetrics and Gynecology 2013 (February 13, 2013): 1–8. http://dx.doi.org/10.1155/2013/979345.
Повний текст джерелаKshirsagar, Malti, Wei Jiang, and Ie-Ming Shih. "DNA Damage Response is Prominent in Ovarian High-Grade Serous Carcinomas, Especially Those with Rsf-1 (HBXAP) Overexpression." Journal of Oncology 2012 (2012): 1–7. http://dx.doi.org/10.1155/2012/621685.
Повний текст джерелаVang, Russell, Ie-Ming Shih, and Robert J. Kurman. "Ovarian Low-grade and High-grade Serous Carcinoma." Advances in Anatomic Pathology 16, no. 5 (September 2009): 267–82. http://dx.doi.org/10.1097/pap.0b013e3181b4fffa.
Повний текст джерелаMoss, Esther Louise, Tim Evans, Philippa Pearmain, Sarah Askew, Kavita Singh, Kiong K. Chan, Raji Ganesan, and Lynn Hirschowitz. "Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?" International Journal of Gynecologic Cancer 25, no. 7 (September 2015): 1201–7. http://dx.doi.org/10.1097/igc.0000000000000477.
Повний текст джерелаVoutsadakis, Ioannis A. "Low-grade serous ovarian carcinoma: an evolution toward targeted therapy." International Journal of Gynecologic Cancer 30, no. 10 (November 27, 2019): 1619–26. http://dx.doi.org/10.1136/ijgc-2019-000832.
Повний текст джерелаKenda Šuster, Nataša, Snježana Frković Grazio, Irma Virant-Klun, Ivan Verdenik, and Špela Smrkolj. "Cancer Stem Cell–Related Marker NANOG Expression in Ovarian Serous Tumors: A Clinicopathological Study of 159 Cases." International Journal of Gynecologic Cancer 27, no. 9 (November 2017): 2006–13. http://dx.doi.org/10.1097/igc.0000000000001105.
Повний текст джерелаRicciardi, Enzo, Thaïs Baert, Beyhan Ataseven, Florian Heitz, Sonia Prader, Mareike Bommert, Stephanie Schneider, Andreas du Bois, and Philipp Harter. "Low-grade Serous Ovarian Carcinoma." Geburtshilfe und Frauenheilkunde 78, no. 10 (October 2018): 972–76. http://dx.doi.org/10.1055/a-0717-5411.
Повний текст джерелаDe Leo, Antonio, Donatella Santini, Claudio Ceccarelli, Giacomo Santandrea, Andrea Palicelli, Giorgia Acquaviva, Federico Chiarucci, et al. "What Is New on Ovarian Carcinoma: Integrated Morphologic and Molecular Analysis Following the New 2020 World Health Organization Classification of Female Genital Tumors." Diagnostics 11, no. 4 (April 14, 2021): 697. http://dx.doi.org/10.3390/diagnostics11040697.
Повний текст джерелаWu, Jingjing, and Jian-Jun Wei. "HMGA2 and high-grade serous ovarian carcinoma." Journal of Molecular Medicine 91, no. 10 (May 19, 2013): 1155–65. http://dx.doi.org/10.1007/s00109-013-1055-8.
Повний текст джерелаBajaj, Anubha. "The Flagellate Transition- Serous Carcinoma Ovary." Women's Health Science Journal 6, no. 1 (2022): 1–4. http://dx.doi.org/10.23880/whsj-16000166.
Повний текст джерелаSeidman, Jeffrey D., Anna Yemelyanova, Jonathan A. Cosin, Anthony Smith, and Robert J. Kurman. "Survival Rates for International Federation of Gynecology and Obstetrics Stage III Ovarian Carcinoma by Cell Type: A Study of 262 Unselected Patients With Uniform Pathologic Review." International Journal of Gynecologic Cancer 22, no. 3 (March 2012): 367–71. http://dx.doi.org/10.1097/igc.0b013e31823c6f80.
Повний текст джерелаBoyd, Clinton, and W. Glenn McCluggage. "Low-Grade Ovarian Serous Neoplasms (Low-Grade Serous Carcinoma and Serous Borderline Tumor) Associated With High-Grade Serous Carcinoma or Undifferentiated Carcinoma." American Journal of Surgical Pathology 36, no. 3 (March 2012): 368–75. http://dx.doi.org/10.1097/pas.0b013e31823732a9.
Повний текст джерелаPunzón-Jiménez, Paula, Victor Lago, Santiago Domingo, Carlos Simón, and Aymara Mas. "Molecular Management of High-Grade Serous Ovarian Carcinoma." International Journal of Molecular Sciences 23, no. 22 (November 9, 2022): 13777. http://dx.doi.org/10.3390/ijms232213777.
Повний текст джерелаCojocaru, E., C. A. Parkinson, and J. D. Brenton. "Personalising Treatment for High-Grade Serous Ovarian Carcinoma." Clinical Oncology 30, no. 8 (August 2018): 515–24. http://dx.doi.org/10.1016/j.clon.2018.05.008.
Повний текст джерелаSANTILLAN, A., Y. W. KIM, M. L. ZAHURAK, G. J. GARDNER, R. L. GIUNTOLI, I. M. SHIH, and R. E. BRISTOW. "Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma." International Journal of Gynecological Cancer 17, no. 3 (May 2007): 601–6. http://dx.doi.org/10.1111/j.1525-1438.2007.00820.x.
Повний текст джерелаGokadze, Nadezhda, Vladimir Selchuk, G. Krasnoshchekova, Yuliya Payanidi, Svetlana Vinokurova, and Kirill Zhordania. "IMMUNOCYTOCHEMICAL ANALYSIS OF ASPIRATION MATERIAL FROM THE UTERINE SEROUS OVARIAN CANCER DETECTION." Problems in oncology 66, no. 2 (February 1, 2020): 160–66. http://dx.doi.org/10.37469/0507-3758-2020-66-2-160-166.
Повний текст джерелаKohn, Elise C., and S. Percy Ivy. "Whence High-Grade Serous Ovarian Cancer." American Society of Clinical Oncology Educational Book, no. 37 (May 2017): 443–48. http://dx.doi.org/10.1200/edbk_174718.
Повний текст джерелаOkoye, Ekene, Elizabeth D. Euscher, and Anais Malpica. "Ovarian Low-grade Serous Carcinoma." American Journal of Surgical Pathology 40, no. 5 (May 2016): 627–35. http://dx.doi.org/10.1097/pas.0000000000000615.
Повний текст джерелаGross, Amy L., Robert J. Kurman, Russell Vang, Ie-Ming Shih, and Kala Visvanathan. "Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics." Journal of Oncology 2010 (2010): 1–9. http://dx.doi.org/10.1155/2010/126295.
Повний текст джерелаKoshiyama, Masafumi, Noriomi Matsumura, and Ikuo Konishi. "Recent Concepts of Ovarian Carcinogenesis: Type I and Type II." BioMed Research International 2014 (2014): 1–11. http://dx.doi.org/10.1155/2014/934261.
Повний текст джерелаKepuladze, Shota, Tamar Dzotsenidze, Arsen Gvenetadze, Mariam Gachechiladze, and George Burkadze. "Immunohistochemical phenotype of fallopian tubes in patients with different grades of serous ovarian carcinoma." Indian Journal of Pathology and Oncology 9, no. 4 (December 15, 2022): 301–5. http://dx.doi.org/10.18231/j.ijpo.2022.073.
Повний текст джерелаDowson, Cassandra B., Colin Stewart, Sarah O'Sullivan, Nicholas Pachter, Lyn Schofield, and Paul A. Cohen. "Incidence of germline BRCA1/2 mutations in women with tubo-ovarian high-grade serous carcinomas with and without serous tubal intra-epithelial carcinomas." International Journal of Gynecologic Cancer 30, no. 1 (November 7, 2019): 94–99. http://dx.doi.org/10.1136/ijgc-2019-000540.
Повний текст джерелаGeorgescu, Tiberiu-Augustin, Roxana Bohiltea, Octavian Munteanu, Corina Grigoriu, Ioana Paunica, and Maria Sajin. "A mini-review regarding the carcinogenesis and morphology of serous tumors of the ovary, fallopian tube and peritoneum." Journal of Mind and Medical Sciences 8, no. 1 (April 15, 2021): 44–52. http://dx.doi.org/10.22543/7674.81.p4452.
Повний текст джерелаSalvador, Shannon, Blake Gilks, Martin Köbel, David Huntsman, Barry Rosen, and Dianne Miller. "The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous Carcinomas." International Journal of Gynecologic Cancer 19, no. 1 (2009): 58–64. http://dx.doi.org/10.1111/igc.0b013e318199009c.
Повний текст джерелаStur, Elaine, Sara Corvigno, Mingchu Xu, Ken Chen, Yukun Tan, Sanghoon Lee, Jinsong Liu, et al. "Spatially resolved transcriptomics of high-grade serous ovarian carcinoma." iScience 25, no. 3 (March 2022): 103923. http://dx.doi.org/10.1016/j.isci.2022.103923.
Повний текст джерелаBromley, Amy B., Alon D. Altman, Pamela Chu, Jill G. Nation, Gregg S. Nelson, Praful Ghatage, Steve E. Kalloger, Guangming Han, and Martin Köbel. "Architectural Patterns of Ovarian/Pelvic High-grade Serous Carcinoma." International Journal of Gynecological Pathology 31, no. 5 (September 2012): 397–404. http://dx.doi.org/10.1097/pgp.0b013e31824c2372.
Повний текст джерелаO'Neill, C. J., H. A. McBride, L. E. Connolly, M. T. Deavers, A. Malpica, and W. G. McCluggage. "High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour." Histopathology 50, no. 6 (May 2007): 773–79. http://dx.doi.org/10.1111/j.1365-2559.2007.02682.x.
Повний текст джерелаSantandrea, Giacomo, Simonetta Piana, Riccardo Valli, Magda Zanelli, Elisa Gasparini, Antonio De Leo, Vincenzo Dario Mandato, and Andrea Palicelli. "Immunohistochemical Biomarkers as a Surrogate of Molecular Analysis in Ovarian Carcinomas: A Review of the Literature." Diagnostics 11, no. 2 (January 29, 2021): 199. http://dx.doi.org/10.3390/diagnostics11020199.
Повний текст джерелаNahar, Begum Afrin, Rama Saha, Chhanda Das, and Gourishankar Kamilya. "Immunohistochemical expression of human epididymis 4 in ovarian malignancy." International Journal of Research in Medical Sciences 7, no. 12 (November 27, 2019): 4493. http://dx.doi.org/10.18203/2320-6012.ijrms20195506.
Повний текст джерелаManchana, Tarinee, Ruangsak Lertkhachonsuk, and Chinachote Teerapakpinyo. "Somatic BRCA Mutation in High Grade Epithelial Ovarian Cancer Patients." Asian Pacific Journal of Cancer Biology 3, no. 4 (January 9, 2019): 99–103. http://dx.doi.org/10.31557/apjcb.2018.3.4.99-103.
Повний текст джерелаLevanon, Keren, Christopher Crum, and Ronny Drapkin. "New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact." Journal of Clinical Oncology 26, no. 32 (November 10, 2008): 5284–93. http://dx.doi.org/10.1200/jco.2008.18.1107.
Повний текст джерелаKim, Jaeyeon, Eun Park, Olga Kim, Jeanne Schilder, Donna Coffey, Chi-Heum Cho, and Robert Bast. "Cell Origins of High-Grade Serous Ovarian Cancer." Cancers 10, no. 11 (November 12, 2018): 433. http://dx.doi.org/10.3390/cancers10110433.
Повний текст джерелаKhatun, Dr Most Fatema, Dr Md Zahangir Alam, Dr Md Bani Amin, Dr Milan Kumar Saha, Dr Shamima Hamid, and Dr Md Samsuzzaman Khan. "Study on P53 Expression in Association with Histopathological Grading of Ovarian Serous Carcinoma." Scholars Journal of Applied Medical Sciences 9, no. 10 (October 24, 2021): 1584–90. http://dx.doi.org/10.36347/sjams.2021.v09i10.019.
Повний текст джерелаUlianova, E. P., E. M. Nepomnyashchaya, G. V. Zhukova, A. B. Sagakyants, D. Yu Yakubova, and O. G. Shulgina. "ABC transporters in the development of platinum drug resistance in serous ovarian carcinoma." CLINICAL AND EXPERIMENTAL MORPHOLOGY 11, no. 2 (2022): 13–21. http://dx.doi.org/10.31088/cem2022.11.2.13-21.
Повний текст джерелаSALANI, R., R. J. KURMAN, R. GIUNTOLI, G. GARDNER, R. BRISTOW, T. L. WANG, and I. M. SHIH. "Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance." International Journal of Gynecologic Cancer 18, no. 3 (May 2008): 487–91. http://dx.doi.org/10.1111/j.1525-1438.2007.01039.x.
Повний текст джерелаEstrella, Jeannelyn S., Judith K. Wolf, and Michael T. Deavers. "Ovarian Serous Carcinoma Associated With a Distinct “Corded and Hyalinized” Pattern." Archives of Pathology & Laboratory Medicine 137, no. 2 (February 1, 2013): 275–79. http://dx.doi.org/10.5858/arpa.2011-0200-cr.
Повний текст джерелаMorency, Elizabeth, Mario M. Leitao, and Robert A. Soslow. "Low-Stage High-Grade Serous Ovarian Carcinomas." International Journal of Gynecological Pathology 35, no. 3 (May 2016): 222–29. http://dx.doi.org/10.1097/pgp.0000000000000256.
Повний текст джерелаOsman Mohamed, Aisha, Nazik Elmalaika Husain, Rawia Eljaili Elmassry, Lubna Alnageeb, Mohammed Elhassan, and Mohammed Siddig Abdelaziz. "Immunohistochemical expression of p53 in Type I and II epithelial ovarian cancer among Sudanese women: a cross-sectional study." F1000Research 8 (October 10, 2019): 1739. http://dx.doi.org/10.12688/f1000research.20608.1.
Повний текст джерелаParis, Elizabeth A., Janice M. Bahr, Sanjib Basu, and Animesh Barua. "Changes in Nucleolin Expression during Malignant Transformation Leading to Ovarian High-Grade Serous Carcinoma." Cancers 15, no. 3 (January 21, 2023): 661. http://dx.doi.org/10.3390/cancers15030661.
Повний текст джерелаCho, Kathleen R. "Ovarian Cancer Update: Lessons From Morphology, Molecules, and Mice." Archives of Pathology & Laboratory Medicine 133, no. 11 (November 1, 2009): 1775–81. http://dx.doi.org/10.5858/133.11.1775.
Повний текст джерелаZhang, Li, Po Ding, Hongcheng Lv, Dan Zhang, Guang Liu, Zhengduo Yang, Yan Li, Jun Liu, and Shiwu Zhang. "Number of Polyploid Giant Cancer Cells and Expression of EZH2 Are Associated with VM Formation and Tumor Grade in Human Ovarian Tumor." BioMed Research International 2014 (2014): 1–9. http://dx.doi.org/10.1155/2014/903542.
Повний текст джерелаDergham, Ana Paula, Caroline Busatta Vaz de Paula, Seigo Nagashima, Márcia Olandoski, Lucia de Noronha, and Vanessa Santos Sotomaior. "Immunohistochemical Profiling of PD-1, PD-L1, CD8, MSI, and p53 and Prognostic Implications in Advanced Serous Ovarian Carcinoma: A Retrospective Study." Journal of Personalized Medicine 13, no. 7 (June 26, 2023): 1045. http://dx.doi.org/10.3390/jpm13071045.
Повний текст джерелаKutlvasr, K., K. Bukovjan, and R. Kodet. "Bilateral low grade serous adenocarcinoma of the ovaries in a badger (Meles meles L.) and its association with a borderline serous ovarian tumour: a case report." Veterinární Medicína 59, No. 1 (February 14, 2014): 44–50. http://dx.doi.org/10.17221/7245-vetmed.
Повний текст джерелаKhashaba, Marwa, Reham Nagib, azza abdelaziz, Ghada Eladawy, and Mohammed Mohamed. "Clinicopathological and Immunohistochemical Study of High Grade Serous Ovarian Carcinoma." Medicine Updates 2, no. 2 (July 1, 2020): 15–37. http://dx.doi.org/10.21608/muj.2020.29356.1011.
Повний текст джерелаKurman, R. J. "Origin and molecular pathogenesis of ovarian high-grade serous carcinoma." Annals of Oncology 24 (December 2013): x16—x21. http://dx.doi.org/10.1093/annonc/mdt463.
Повний текст джерелаChen, Gregory M., Lavanya Kannan, Ludwig Geistlinger, Victor Kofia, Zhaleh Safikhani, Deena M. A. Gendoo, Giovanni Parmigiani, Michael Birrer, Benjamin Haibe-Kains, and Levi Waldron. "Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma." Clinical Cancer Research 24, no. 20 (July 3, 2018): 5037–47. http://dx.doi.org/10.1158/1078-0432.ccr-18-0784.
Повний текст джерелаSingh, Naveena, W. Glenn McCluggage, and C. Blake Gilks. "High-grade serous carcinoma of tubo-ovarian origin: recent developments." Histopathology 71, no. 3 (July 18, 2017): 339–56. http://dx.doi.org/10.1111/his.13248.
Повний текст джерелаMessini, Irini, Triada Doulgeraki, Dimitris Chrysanthakis, Petros Yiannou, Theofani Gavresea, Christos Papadimitriou, Theodoros Panoskaltsis, Zannis Voulgaris, Athanassios Vlachos, and Kitty Pavlakis. "Assessing the landscape of ovarian serous borderline tumors." International Journal of Gynecologic Cancer 29, no. 3 (January 18, 2019): 572–78. http://dx.doi.org/10.1136/ijgc-2018-000086.
Повний текст джерелаGilks, C. Blake. "Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma." Journal of Oncology 2010 (2010): 1–7. http://dx.doi.org/10.1155/2010/740968.
Повний текст джерела